Your search returned 58 studies. (Get alerts for new studies):
- A Dose Escalation Study of an Antibody in Patients With Advanced Cancers
Conditions: Advanced Cancers
2 Locations available
- Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
Conditions: Advanced Cancers
1 Location available
- Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer
Conditions: Advanced Cancers
1 Location available
- A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Solid Cancers
3 Locations available
- Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: Advanced Cancers - Leukemia
1 Location available
- A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
10 Locations available
- Erlotinib in Combination With Cetuximab
Conditions: Advanced Cancers
1 Location available
- Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors
Conditions: Advanced Cancers
1 Location available
- A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers
Conditions: Advanced Solid Cancers
1 Location available
- Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
Conditions: Endometrial Cancer
1 Location available
- An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status
Conditions: Advanced Cancers
1 Location available
- A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
Conditions: Advanced or Metastatic Solid Tumors - Cancer - Solid Cancers
4 Locations available
- Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab
Conditions: Advanced Cancers
1 Location available
- Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Periampullary Adenocarcinoma
7 Locations available
- Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor
Conditions: Advanced Cancers - Sarcoma
1 Location available
- Bevacizumab, Temsirolimus, Valproic Acid, Cetuximab
Conditions: Advanced Cancers
1 Location available
- PXD101 and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors
Conditions: Non-Small Cell Lung Cancer, Solid Cancers
2 Locations available
- A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Solid Cancers
3 Locations available
- Phase I, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients With Advanced Cancers
Conditions: Advanced Cancers
2 Locations available
- Early Detection of Cardiotoxicity During Sunitinib or Sorafenib Chemotherapy Using Cardiac Biomarkers
Conditions: Advanced Cancers
1 Location available
- Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients
Conditions: Advanced Cancers
1 Location available
- Clinical Response to Chemotherapy With Fluoro-L-Thymidine With Positron Emission Tomography (FLT-PET)
Conditions: Advanced Cancers
1 Location available
- A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers
Conditions: Small Cell Lung Carcinoma - Malignant Epithelial Neoplasms
1 Location available
- Dyspnea in Advanced Cancer Patients
Conditions: Advanced Cancers
1 Location available
- A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers
Conditions: Metastatic Cancer
2 Locations available
- GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors
Conditions: Solid Cancers
3 Locations available
- Vemurafenib and Sorafenib in Advanced Cancer
Conditions: Advanced Cancers
1 Location available
- Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumor Cancers - Medulloblastoma - Basal Cell Carcinoma
2 Locations available
- HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver
Conditions: Liver Cancer - Advanced Cancer
1 Location available
- Physician Perceptions About Parenteral Hydration in Latin America and Spain
Conditions: Dehydration - Advanced Cancers
1 Location available
- A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Me
Conditions: Solid Cancers
3 Locations available
- Bendamustine and Bevacizumab for Advanced Cancers
Conditions: Advanced Cancer
1 Location available
- Tolvaptan in Hyponatremic Cancer Patients
Conditions: Advanced Cancers
1 Location available
- CYCORE Feasibility
Conditions: Advanced Cancers - Colorectal Cancer - Head And Neck Cancer - Cancer Survivors
1 Location available
- Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Sol
Conditions: Solid Cancers
4 Locations available
- End of Life Treatment Preferences
Conditions: Advanced Cancers
1 Location available
- Breakthrough Dyspnea Fentanyl Study
Conditions: Advanced Cancers - Dyspnea
1 Location available
- A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffe
Conditions: Solid Cancers
3 Locations available
- Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab
Conditions: Advanced Cancers
1 Location available
- A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
Conditions: Thyroid Neoplasm
1 Location available
- Bevacizumab With Capecitabine and Oxaliplatin in Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater
Conditions: Gastrointestinal Cancers
1 Location available
- A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
Conditions: Colorectal Cancer - Squamous Cell Head and Neck Cancer - Non-small Cell Lung Cancer - Triple Negative Breast Cancer - Other Tumors With EGFR Dependence
2 Locations available
- Erlotinib in Combination With Pralatrexate in Advanced Malignancies
Conditions: Advanced Cancers - Solid Tumors
1 Location available
- Crizotinib and STA-9090 in ALK Positive Lung Cancers
Conditions: Advanced Lung Cancer
5 Locations available
- Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
Conditions: Advanced Cancers
1 Location available
- Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers
Conditions: Advanced Cancer
3 Locations available
- Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol
Conditions: Advanced Cancers
1 Location available
- 5-Azacytidine and Oxaliplatin With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy
Conditions: Advanced Cancer - Solid Tumor - Lymphoma
1 Location available
- HAI Abraxane With Gemcitabine and Bevacizumab
Conditions: Advanced Cancers
1 Location available
- Lapatinib With Sirolimus or Metformin
Conditions: Advanced Cancers
1 Location available
- A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers
Conditions: Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer, - Primary Peritoneal Cancer or Endometrial Cancer - Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer
3 Locations available
- Ginseng on Cancer-Related Fatigue
Conditions: Advanced Cancers - Solid Tumors
1 Location available
- Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients
Conditions: Advanced Cancers - Solid Tumors
1 Location available
- Safety and Pharmacology of GDC-0068 in Combination With Either Docetaxel or Fluoropyrimidine Plus Oxaliplatin in Patients With Advanced Solid Tumors
Conditions: Solid Cancers
2 Locations available
- Temsirolimus in Combination With Metformin in Patients With Advanced Cancers
Conditions: Advanced Cancers
1 Location available
- Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer
Conditions: Advanced Cancers
1 Location available
- Vandetanib With Everolimus
Conditions: Advanced Cancers
1 Location available
|